Clinical Trial Update: Vitamin D 24'000 IU for Oral Intermittent Supplementation [Phase 3]

View source ↗

Summary

Phase 3 trial of intermittent high-dose vitamin D (24,000 IU) for vitamin D deficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitamin Deficiency

Drugs mentioned

• Vitamin D (Cholecalciferol)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Vitamin D Deficiency | Phase 3 | Status: COMPLETED